← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 7, 2014Last known activity
Apr 30, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT04239092CollaboratorPhase 1Apr 30, 2020
- NCT04218071CollaboratorPhase 2Mar 31, 2020
- NCT04218071Study chairPhase 2Mar 31, 2020
- NCT03678883Overall official - principal investigatorPhase 1/Phase 2Nov 30, 2018
- NCT03678883CollaboratorPhase 1/Phase 2Nov 30, 2018
- NCT02228382CollaboratorPhase 4Nov 7, 2014
Details
- Founded
- Bethesda, MD, US
- Last known activity
- Apr 30, 2020
Notes
part of the National Cancer Institute (NCI)